Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SNCA REP1 and Parkinson's disease.

Li Shu1, Yuan Zhang1, Qiying Sun2

  • 1Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Neuroscience Letters
|June 3, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haplotype-resolved long-read sequencing reveals parent-of-origin effects of tandem-repeat variation in autism spectrum disorder.

Science bulletin·2026
Same author

The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohort.

NPJ Parkinson's disease·2026
Same author

Large-scale profiling of blood microbial signatures in patients with Parkinson's disease and its association with disease progression: a cross-sectional study.

EBioMedicine·2026
Same author

Shared genetic architecture between sleep traits and cardiometabolic diseases.

EBioMedicine·2026
Same author

Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial.

Signal transduction and targeted therapy·2026
Same author

Short tandem repeat expansions in patients with neurodegenerative dementia.

EBioMedicine·2026

This study analyzed REP1 alleles and Parkinson's disease (PD) risk, finding specific alleles increase PD risk while others decrease it. Allele variations also influence PD onset and vary significantly across different ethnicities.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • The SNCA gene's promoter region contains the REP1 dinucleotide repeat, a known polymorphic site.
  • Previous studies on REP1 alleles and Parkinson's disease (PD) risk have yielded inconsistent results.
  • A comprehensive analysis of REP1's association with PD and its phenotypes is needed.

Purpose of the Study:

  • To systematically analyze the association between REP1 alleles and Parkinson's disease (PD) risk.
  • To investigate the relationship between REP1 variations and PD phenotypes, including age of onset.
  • To examine population heterogeneity in these associations across different ethnicities.

Main Methods:

  • Systematic literature search of Medline, Embase, Cochrane, Wanfang, and CNKI databases.
Keywords:
Meta-analysisPhenotypeRep1SNCAVariant

Related Experiment Videos

  • Inclusion and exclusion criteria were strictly applied to selected studies.
  • Meta-analysis was performed using Revman 5.3 software to assess risks and heterogeneity.

    • Main Results:

    • The 265-, 269-, and 271-bp REP1 alleles were associated with increased PD risk (OR > 1), while the 267-bp allele was associated with decreased risk (OR < 1) globally.
    • Significant population heterogeneity was observed; for instance, in Caucasians, 269-, 271-, and 273-bp alleles increased PD risk, while in Asians, 263- and 265-bp alleles increased risk.
    • The 271-bp allele was linked to early-onset PD, whereas the 267-bp allele showed an association with later onset.

    Conclusions:

    • Specific REP1 alleles significantly influence Parkinson's disease risk, with varying effects across global populations and ethnicities.
    • REP1 allele variations are associated with PD phenotypes, notably age of onset.
    • This meta-analysis clarifies the complex role of REP1 in PD pathogenesis and highlights the importance of ethnic background in genetic risk assessment.